Offerings // Nanobiotix S.A.

NBTX offering history

Every offering-related filing in Nanobiotix S.A.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 301 filings back to Dec 21, 2018.

Last executed offering

May 22, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Mar 6, 2025

F-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
May 22, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 22, 2026	FWP →	MARKETING	Free-writing prospectus — offering being marketed
May 21, 2026	FWP →	MARKETING	Free-writing prospectus — offering being marketed
May 21, 2026	FWP →	MARKETING	Free-writing prospectus — offering being marketed
May 20, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 14, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 6, 2025	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Nov 6, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 2, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 2, 2023	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Nov 2, 2023	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Feb 16, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 4, 2022	F-3 →	REGISTERED	F-3 registration — capacity to sell shares, not a sale yet
Dec 11, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 11, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 10, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 10, 2020	F-1MEF →	REGISTERED	F-1MEF registration — capacity to sell shares, not a sale yet
Dec 10, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 10, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 9, 2020	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Dec 7, 2020	F-1/A →	REGISTERED	F-1/A registration — capacity to sell shares, not a sale yet
Nov 20, 2020	F-1 →	REGISTERED	F-1 registration — capacity to sell shares, not a sale yet

NBTX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full NBTX workspace →

NBTX offering FAQ

When did NBTX last execute an offering?

Per SEC filings, Nanobiotix S.A.'s most recent priced offering document is a 424B5 filed 2026-05-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did NBTX last announce or register an offering?

The most recent registration is a F-3 filed 2025-03-06. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.